SCHEDULE 13G: Perceptive Advisors and Affiliates Disclose 9.5% Stake in Outset Medical, Inc.

Perceptive Advisors LLC, Joseph Edelman, and affiliated entities have disclosed a 9.5% beneficial ownership stake in Outset Medical, Inc., primarily through warrants.

Summary

• Perceptive Advisors LLC, Joseph Edelman, Perceptive Credit Advisors LLC, and Perceptive Credit Holdings IV, LP (collectively, the "Reporting Persons") have filed a Schedule 13G indicating beneficial ownership of Outset Medical, Inc. common stock.
• The Reporting Persons collectively beneficially own 5,625,000 shares of Outset Medical, Inc. common stock.
• This ownership represents 9.5% of the Issuer's outstanding common stock.
• The ownership percentage is calculated based on 53,896,936 shares of Common Stock outstanding as of February 24, 2025, as reported in Outset Medical's Annual Report on Form 10-K filed on February 28, 2025.
• The stake primarily consists of warrants held by Perceptive Credit Holdings IV, LP, which are exercisable for 5,625,000 shares of Common Stock.
• The warrants include a limitation preventing their exercise if it would result in the Reporting Persons beneficially owning more than 9.99% of the Issuer's outstanding shares.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a reputable institutional investor like Perceptive Advisors is generally viewed positively, indicating confidence in the company. While it's a passive filing, the nature of the investor and the size of the stake suggest a favorable outlook from their perspective.

Positives

• A significant stake by an institutional investor like Perceptive Advisors can be viewed as a vote of confidence in Outset Medical, Inc.'s future prospects.
• The investment firm's focus on healthcare and life sciences suggests a strategic interest in Outset Medical's position within the medical device sector.

Risks

• The beneficial ownership is primarily through warrants, which introduces a dependency on the future stock price for the full realization of the investment's value.
• The 9.99% exercise limitation on the warrants means the Reporting Persons cannot increase their stake beyond this threshold through warrant exercise, potentially limiting their influence or further investment via this mechanism.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from Outset Medical, Inc. or the Reporting Persons regarding the Issuer's future performance.

Management Comments

• Joseph Edelman, on behalf of Perceptive Advisors LLC, Joseph Edelman, Perceptive Credit Advisors LLC, and Perceptive Credit Holdings IV, LP, certified that 'to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.'

Industry Context

Outset Medical, Inc. operates in the medical device industry, specializing in innovative dialysis technology. The investment by Perceptive Advisors, a firm known for its focus on the healthcare and life sciences sectors, aligns with broader industry trends of institutional investment in companies developing advanced medical solutions.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an institutional investor may instill confidence among existing shareholders and potentially attract new investors, positively influencing stock perception.
• Company Management: Awareness of a large, passive institutional holder may influence strategic decisions, though the filing explicitly states no intent to change or influence control.

Key Dates

Keywords

Outset Medical, Perceptive Advisors, Joseph Edelman, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investor, Medical Devices, Healthcare, SEC Filing